ProfileGDS4718 / 215872_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 14% 18% 15% 18% 19% 18% 23% 22% 22% 19% 19% 15% 18% 21% 23% 14% 20% 25% 20% 28% 22% 21% 16% 20% 18% 23% 14% 16% 20% 21% 24% 23% 20% 15% 19% 15% 20% 19% 16% 18% 17% 20% 21% 17% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.9395214
GSM549102patient 115, normal, homogenized [OPG study]4.0879818
GSM549104patient 119, normal, homogenized [OPG study]3.9395815
GSM549108patient 138, normal, homogenized [OPG study]4.1115818
GSM549119patient 077, normal, homogenized [OPG study]4.1055219
GSM549133patient 032, cancer, homogenized [OPG study]4.0262518
GSM549139patient 042, cancer, homogenized [OPG study]4.243723
GSM549099patient 107, normal, homogenized [OPG study]4.224522
GSM549109patient 139, normal, homogenized [OPG study]4.250222
GSM549110patient 046, normal, homogenized [OPG study]4.1164419
GSM549114patient 063, normal, homogenized [OPG study]4.0852119
GSM549122patient 082, normal, homogenized [OPG study]3.9660815
GSM549134patient 033, cancer, homogenized [OPG study]4.0761718
GSM549136patient 036, cancer, homogenized [OPG study]4.1348821
GSM549140patient 044, cancer, homogenized [OPG study]4.2060623
GSM549111patient 047, normal, homogenized [OPG study]3.9074914
GSM549113patient 057, normal, homogenized [OPG study]4.0874520
GSM549132patient 031, cancer, homogenized [OPG study]4.3427725
GSM549137patient 038, cancer, homogenized [OPG study]4.1425520
GSM549142patient 047, cancer, homogenized [OPG study]4.5560128
GSM549100patient 110, normal, homogenized [OPG study]4.2182722
GSM549107patient 135, normal, homogenized [OPG study]4.1630521
GSM549115patient 068, normal, homogenized [OPG study]3.9497416
GSM549116patient 072, normal, homogenized [OPG study]4.1171420
GSM549120patient 078, normal, homogenized [OPG study]4.0710618
GSM549131patient 030, cancer, homogenized [OPG study]4.2015123
GSM549118patient 074, normal, homogenized [OPG study]3.9397314
GSM549129patient 027, cancer, homogenized [OPG study]3.9938916
GSM549123patient 088, normal, homogenized [OPG study]4.1487120
GSM549124patient 006, cancer, homogenized [OPG study]4.2403521
GSM549126patient 015, cancer, homogenized [OPG study]4.2863624
GSM549128patient 025, cancer, homogenized [OPG study]4.2306823
GSM549103patient 117, normal, homogenized [OPG study]4.1854820
GSM549117patient 073, normal, homogenized [OPG study]3.958715
GSM549138patient 041, cancer, homogenized [OPG study]4.0931519
GSM549141patient 045, cancer, homogenized [OPG study]3.9249115
GSM549130patient 028, cancer, homogenized [OPG study]4.153820
GSM549101patient 111, normal, homogenized [OPG study]4.1061819
GSM549105patient 128, normal, homogenized [OPG study]4.0053516
GSM549106patient 134, normal, homogenized [OPG study]4.0126118
GSM549112patient 048, normal, homogenized [OPG study]4.0382617
GSM549125patient 011, cancer, homogenized [OPG study]4.1557220
GSM549127patient 024, cancer, homogenized [OPG study]4.1587421
GSM549135patient 035, cancer, homogenized [OPG study]3.992117